East Windsor, United States
ForDoz Pharma Corp, headquartered in the United States, operates as a leading CDMO (Contract Development and Manufacturing Organization) specializing in sterile drug products. Established in 2014, the company sets itself apart with its advanced capabilities encompassing conventional sterile injectables and cutting-edge technologies. These include lyophilized formulations, liposomal & nanoparticle delivery systems, microsphere & polymer-controlled release systems, and in situ depot formulations.
Based in East Windsor, New Jersey, ForDoz aims to meet significant unmet medical needs by focusing on novel, complex injectable therapeutics. The U.S. market has lagged in sterile injectable production, a gap that ForDoz addresses with its comprehensive end-to-end offerings.
This strategic position allows ForDoz Pharma Corp to tackle issues like prolonged circulation times, improved solubility, and sustained drug release effectively, thereby catering to the growing demand for both conventional and complex sterile formulations in the pharmaceutical manufacturing sector.
